247 top medical experts on Hypertensive Intracranial Hemorrhage across 33 countries and 16 U.S. states, including 123 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hypertensive Intracranial Hemorrhage: Bleeding within the skull that is caused by systemic hypertension, usually in association with intracranial arteriosclerosis. Hypertensive hemorrhages are most frequent in the basal ganglia; cerebellum; pons; and thalamus; but may also involve the cerebral cortex, subcortical white matter, and other brain structures.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Intracranial Hemorrhages (3,242).
  4. Clinical Trials ClinicalTrials.gov : at least 16 including 4 Completed, 1 Recruiting
  5. Synonyms: Hypertensive Cerebral Hemorrhage,  Intracranial Hypertensive Hemorrhage,  Hypertensive Intracerebral Hemorrhage


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Kamel, Hooman   Neurology  Google Publications
    Division of Neurocritical Care J.L., S.B.M., M.E.F., A.E.M., H.K., Weill Cornell Medicine, New York, NY.
    Physician  Highly Published 
    Disclosed payments in 2021 from 9 biomedical companies, totalling $7,805, including $5,510 from  Boehringer Ingelheim International GmbH
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Emergency Service, Hospital
    Categories: Complications; Drug Therapy; Pathology; Therapeutic Use; Drug Effects; Etiology
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)
    Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. (2020)

  2. Hanley, Daniel F   Neurology  Google Publications
    Department of Neurology, Johns Hopkins University, Baltimore, MD W.C.Z., D.F.H.. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Disclosed payments from biomedical company (Celltrion, Inc.) in 2021 for $1,500
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Brain Edema; Clinical Trials as Topic; Drainage; Fibrinolytic Agents
    Categories: Therapeutic Use; Drug Therapy; Methods; Pathology; Therapy; Pharmacology
    Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. (2019)
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)

  3. Goldstein, Joshua N   Emergency Medicine  Google Publications
    Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston J.N.G.. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Medical school: University of Connecticut School of Medicine (MD, 2000)
    Medicare Accepted
    Disclosed payments in 2021 from 10 biomedical companies, totalling $38,118.36, including $20,182.5 from  PFIZER INC.
    Subjects: Intracranial Hemorrhage, Hypertensive; Hypertension; Antihypertensive Agents; Blood Pressure; Brain Edema; Genetic Predisposition to Disease
    Categories: Drug Therapy; Genetics; Pathology; Therapeutic Use; Administration & Dosage; Complications
    Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. (2010)
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)

  4. Falcone, Guido J   Neurology  Google Publications
    Department of Neurology, Yale School of Medicine, New Haven, CT G.J.F., K.N.S..
    Physician  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Genetic Predisposition to Disease
    Categories: Genetics; Drug Therapy; Pathology; Therapeutic Use; Complications; Drug Effects
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)
    Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage. (2012)

  5. Awad, Issam A   Neurological Surgery  Google Publications
    Section of Neurosurgery and the Neurovascular Surgery Program, University of Chicago Pritzker School of Medicine, Chicago, IL. Top Hospital
    Physician  Clinical Trial  Case Reports 
    Medical school: Loma Linda University School of Medicine (MD, 1980)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.6/100
    Disclosed payments in 2021 from 4 biomedical companies, totalling $13,148.33, including $13,148.33 from  Neurelis, Inc.
    Subjects: Intracranial Hemorrhage, Hypertensive; Drainage; Fibrinolytic Agents; Hemangioma, Cavernous, Central Nervous System; Hypertension; Intracranial Hypertension
    Categories: Diagnosis; Therapeutic Use; Therapy; Complications; Methods
    Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. (2019)
    Fatal hypertensive intracerebral hemorrhage associated with a cerebral cavernous angioma: case report. (2011)

  6. Yu, Wengui   Neurocritical Care   Google Publications
    Department of Neurology, University of California, Irvine, 200 S. Manchester Ave., Suite 206E, Orange, CA, 92868, USA. .
    Physician 
    Medical school: Other (MD, 1983)
    Medicare Accepted
    Disclosed payments in 2021 from 2 biomedical companies, totalling $800, including $800 from  Penumbra, Inc.
    Subjects: Antihypertensive Agents; Intracranial Hemorrhage, Hypertensive; Fibrinolytic Agents; Hemorrhagic Stroke; Hospital Costs; Hypertension
    Categories: Therapeutic Use; Drug Therapy; Statistics & Numerical Data; Therapy; Administration & Dosage
    Current management of spontaneous intracerebral haemorrhage. (2017)
    Early Initiation of Oral Antihypertensives Reduces Intensive Care Unit Stay and Hospital Cost for Patients with Hypertensive Intracerebral Hemorrhage. (2020)

  7. Ziai, Wendy C   Critical Care Medicine  Google Publications
    Department of Neurology, Johns Hopkins University, Baltimore, MD W.C.Z., D.F.H.. Top Hospital
    Physician  Clinical Trial 
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Brain Edema; Drainage; Fibrinolytic Agents; Intracranial Hypertension
    Categories: Therapeutic Use; Pathology; Therapy; Drug Therapy; Methods
    Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. (2019)
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)

  8. Murthy, Santosh B   Neurology  Google Publications
    Division of Neurocritical Care J.L., S.B.M., M.E.F., A.E.M., H.K., Weill Cornell Medicine, New York, NY.
    Physician 
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Nicardipine
    Categories: Drug Therapy; Pathology; Therapeutic Use; Complications; Drug Effects; Pharmacology
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)
    Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. (2020)

  9. Becker, Jennifer L   Diagnostic Radiology  Google Publications
    Department of Medical Imaging, College of Medicine, The University of Arizona, Tucson, Arizona. Top Hospital
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 74/100
    Subjects: Intracranial Hemorrhage, Hypertensive; Stroke; Antihypertensive Agents; Blood Pressure; Hypertension; Nitric Oxide
    Categories: Drug Therapy; Administration & Dosage; Diagnosis; Therapeutic Use; Drug Effects
    Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial. (2015)
    Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial. (2016)

  10. Qureshi, Adnan I   Neurology   Google Publications
    Zeenat Qureshi Stroke Institute, St. Cloud, MN A.I.Q..
    Physician  Clinical Trial 
    Medical school: Other (MD, 1989)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments in 2021 from 6 biomedical companies, totalling $1,898.69, including $1,611 from  AstraZeneca Pharmaceuticals LP
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Hypertension; Blood Pressure; Brain Edema; Nicardipine
    Categories: Drug Therapy; Pathology; Therapeutic Use; Administration & Dosage; Complications; Drug Effects
    Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. (2010)
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)

  11. Sheth, Kevin N   Neurology  Google Publications
    Department of Neurology, Yale School of Medicine, New Haven, CT G.J.F., K.N.S..
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments in 2021 from 5 biomedical companies, totalling $5,774.65, including $4,000 from  ZOLL Circulation Inc
    Subjects: Intracranial Hemorrhage, Hypertensive; Antihypertensive Agents; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Nicardipine
    Categories: Drug Therapy; Pathology; Therapeutic Use; Complications; Drug Effects; Pharmacology
    Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. (2019)
    Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. (2020)

  12. Dastur, Cyrus K   Neurology  Google Publications
    Department of Neurology, University of California, Irvine, 200 S. Manchester Ave., Suite 206E, Orange, CA, 92868, USA.
    Physician 
    Subjects: Antihypertensive Agents; Intracranial Hemorrhage, Hypertensive; Fibrinolytic Agents; Hemorrhagic Stroke; Hospital Costs; Hypertension
    Categories: Therapeutic Use; Drug Therapy; Statistics & Numerical Data; Therapy; Administration & Dosage
    Current management of spontaneous intracerebral haemorrhage. (2017)
    Early Initiation of Oral Antihypertensives Reduces Intensive Care Unit Stay and Hospital Cost for Patients with Hypertensive Intracerebral Hemorrhage. (2020)

  13. Sheth, Sunil A   Vascular Neurology  Google Publications
    Department of Neurology, University of Texas Health Science Center at Houston.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 89.4/100
    Disclosed payments in 2021 from 13 biomedical companies, totalling $4,855.19, including $3,871.82 from  Imperative Care, Inc
    Subjects: Intracranial Hemorrhage, Hypertensive; Cerebral Angiography; Tomography Scanners, X-Ray Computed
    Categories: Diagnostic Imaging; Etiology
    Atypical Cause of Typical Hypertensive Intracranial Bleeding. (2018)

  14. Frontera, Jennifer A   Neurocritical Care   Google Publications
    Department of Neurology, NYU Langone Health, 150 55th St., Brooklyn, NY, 11231, USA. .
    Physician 
    Medical school: Johns Hopkins University School of Medicine (MD, 2000)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 86/100
    Disclosed payments from biomedical company (Alexion Pharmaceuticals, Inc.) in 2021 for $93.31
    Subjects: Intracranial Hemorrhage, Hypertensive
    Cheap and Cheerful: Early Initiation of Oral Antihypertensives After ICH Saves Time and Money. (2020)

  15. Chen, Zu-Lin  Google Publications
    Laboratory of Neurobiology and Genetics, The Rockefeller University, New York, NY 10065, USA.
    Scientist 
    Subjects: Astrocytes; Intracranial Hemorrhage, Hypertensive; Laminin; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle
    Categories: Pathology; Metabolism
    Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. (2013)

  16. Strickland, Sidney  Google Publications
    Scientist 
    Subjects: Astrocytes; Intracranial Hemorrhage, Hypertensive; Laminin; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle
    Categories: Pathology; Metabolism
    Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. (2013)

  17. Barth, Rolf F   Surgery   Google Publications
    Department of Pathology, The Ohio State University, Columbus, OH 43210. Electronic address: . Top Hospital
    Physician 
    Medical school: Duke University School of Medicine (MD, 1997)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 94/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $618.04, including $493.11 from  SANOFI-AVENTIS U.S. LLC
    Subjects: Hypertension; Intracranial Hemorrhage, Hypertensive; Stroke
    Categories: History
    What did Joseph Stalin really die of? A reappraisal of his illness, death, and autopsy findings. (2019)

  18. Phipps, Michael S   Vascular Neurology   Google Publications
    VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06519, USA.
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 92/100
    Disclosed payments from biomedical company (Takeda Pharmaceuticals U.S.A., Inc.) in 2021 for $29
    Subjects: Cerebrovascular Disorders; Diabetic Angiopathies; Glycated Hemoglobin A; Hypertension; Intracranial Hemorrhage, Hypertensive; Ischemic Attack, Transient
    Categories: Diagnosis; Metabolism
    The diagnosis and management of cerebrovascular disease in diabetes. (2012)

  19. Lin, Jessica   Neurology  Google Publications
    Division of Neurocritical Care J.L., S.B.M., M.E.F., A.E.M., H.K., Weill Cornell Medicine, New York, NY.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $40.08, including $23.45 from  ITI, Inc.
    Subjects: Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Intracranial Hemorrhage, Hypertensive
    Categories: Complications; Drug Effects; Drug Therapy; Pharmacology
    Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. (2020)

  20. Rincon, Fred   Vascular Neurology  Google Publications
    Department of Medicine, Division of Neurology and Critical Care, Cooper University Hospital, University of Medicine and Dentistry of New Jersey, Camden, New Jersey, USA.
    Physician 
    Medical school: Other (MD, 1996)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 67/100
    Disclosed payments in 2021 from 19 biomedical companies, totalling $20,057.32, including $20,057.32 from  Alexion Pharmaceuticals, Inc.
    Subjects: Intracranial Hemorrhage, Hypertensive; Anticoagulants; Antihypertensive Agents; Craniotomy
    Categories: Therapeutic Use; Drug Therapy; Methods; Surgery
    Intracerebral hemorrhage: getting ready for effective treatments. (2010)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);